ELITE PHARMACEUTICALS INC /NV/ Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.07B shares, a 4.8% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.02B shares, a 1.02% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.01B shares, a 0.23% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.01B shares, a 7.17% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.07B +49M +4.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.08B +61.7M +6.08% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.02B +10.3M +1.02% Jan 1, 2024 Mar 31, 2024 10-K 2024-07-01
Q4 2023 1.02B +10.5M +1.04% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 1.02B +7.09M +0.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 1.01B +3.19M +0.32% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 1.01B +2.3M +0.23% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-01
Q4 2022 1.01B +2.63M +0.26% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 1.01B +946K +0.09% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 1.01B +2.18M +0.22% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 1.01B +67.6M +7.17% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-29
Q4 2021 1.01B +2.11M +0.21% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 1.01B +97.7M +10.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 1.01B +8.07M +0.81% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 943M -50.3M -5.06% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-29
Q4 2020 1.01B +180M +21.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 914M +84.2M +10.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 1B +174M +21% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 993M +177M +21.7% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-14
Q4 2019 829M +9.93M +1.21% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 829M +17.1M +2.11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 828M +24.5M +3.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 816M +18.1M +2.27% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 819M +24.3M +3.06% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 812M +23.5M +2.97% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 803M -16.3M -1.99% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 798M -46.3M -5.49% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-21
Q4 2017 795M -115M -12.7% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 789M -27.2M -3.34% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 819M +96.5M +13.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 845M +171M +25.3% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-14
Q4 2016 911M +226M +33% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 816M -7.47M -0.91% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 723M -89.8M -11.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 674M -83.7M -11% Jan 1, 2016 Mar 31, 2016 10-K 2018-06-14
Q4 2015 685M -85.8M -11.1% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 823M +83.6M +11.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 813M +78.7M +10.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 758M +295M +63.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-06-14
Q4 2014 771M +262M +51.5% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 740M +318M +75.3% Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-30
Q2 2014 734M +154M +26.5% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-30
Q1 2014 463M -63.9M -12.1% Jan 1, 2014 Mar 31, 2014 10-K 2016-06-15
Q4 2013 509M +22.4M +4.61% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 422M -83.8M -16.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 580M +243M +72.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 527M Jan 1, 2013 Mar 31, 2013 10-K 2014-06-30
Q4 2012 486M +59.2M +13.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 506M +51.6M +11.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 337M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q4 2011 427M -307B -99.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 454M +154M +51.4% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q4 2010 308B Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 300M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.